DNA-dependent protein kinase is a molecular target for the development of noncytotoxic radiation-sensitizing drugs

Cancer Research

Volumn 65, Issue 12, 2005, Pages 4987-4992

  Shinohara, Eric T ^a   Geng, Ling ^a   Tan, Jiahui ^a   Chen, Heidi ^a   Shir, Yu ^a   Edwards, Eric ^a   Halbrook, James ^c   Kesicki, Edward A ^c   Kashishian, Adam ^c   Hallahan, Dennis E ^a,b,d  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

^c ELI LILLY AND COMPANY   (United States)

^d VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA DEPENDENT PROTEIN KINASE; DOUBLE STRANDED DNA; IC 87361; PROTEIN KINASE INHIBITOR; RADIOSENSITIZING AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER INHIBITION; CYTOTOXICITY; ENDOTHELIUM CELL; ENZYME ACTIVITY; GAMMA RADIATION; MICROVASCULATURE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RADIATION RESPONSE; RADIOSENSITIVITY; RADIOSENSITIZATION; SCID MOUSE; VASCULAR TUMOR; WILD TYPE;

ANIMALS; CARCINOMA, LEWIS LUNG; CELL GROWTH PROCESSES; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; DNA-ACTIVATED PROTEIN KINASE; DNA-BINDING PROTEINS; ENDOTHELIAL CELLS; MELANOMA, EXPERIMENTAL; MICE; MICE, NUDE; MICE, SCID; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN KINASE INHIBITORS; PROTEIN-SERINE-THREONINE KINASES; RADIATION-SENSITIZING AGENTS;

EID: 20444475018     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-4250     Document Type: Article

References (23)

1. Hartley KO, Gell D, Smith GC, et al. DNA-dependent protein kinase catalytic subunit: a relative of phosphatidylinositol 3-kinase and the ataxia telangiectasia gene product. Cell 1995;82:849-56.
2. Kirchgessner CU, Patil CK, Evans JW, et al. DNA-dependent kinase (p350) as a candidate gene for the murine SCID defect. Science 1995;267:1178-83.
3. Wang S, Guo M, Ouyang H, et al. The catalytic subunit of DNA-dependent protein kinase selectively regulates p53-dependent apoptosis but not cell-cycle arrest. Proc Natl Acad Sci U S A 2000;97:1584-8.
4. Mayo LD, Turchi JJ, Berberich SJ. Mdm-2 phosphorylation by DNA-dependent protein kinase prevents interaction with p53. Cancer Res 1997;57: 5013-6.
5. Hunter T. When is a lipid kinase not a lipid kinase? When it is a protein kinase. Cell 1995;83:1-4.
6. Zakian VA, ATM-related genes: what do they tell us about functions of the human gene? Cell 1995; 82:685-7.
7. Gottlieb TM, Jackson SP, Protein kinases and DNA damage. Trends Biochem Sci 1994;19:500-3.
8. Taccioli GE, Gottlieb TM, Blunt T, et al. Ku80: product of the XRCC5 gene and its role in DNA repair and V(D)J recombination. Science 1994;265:1442-5.
9. Dvir A, Peterson SR, Knuth MW, Lu H, Dynan WS. Ku autoantigen is the regulatory component of a template-associated protein kinase that phosphorylates RNA polymerase II. Proc Natl Acad Sci U S A 1992;89: 11920-4.
10. Smith GC, Jackson SP. The DNA-dependent protein kinase. Genes Der 1999;13:916-34.
11. Hendrickson EA, Qin XQ, Bump EA, Schatz DG, Oettinger M, Weaver DT. A link between double-strand break-related repair and V(D)J recombination: the scid mutation. Proc Natl Acad Sci U S A 1991; 88:4061-5.
12. Blunt T, Finnie NJ, Taccioli GE, et al. Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation. Cell 1995; 80:813-23.
13. Fulop GM, Phillips RA. The scid mutation in mice causes a general defect in DNA repair. Nature 1990;347:479-82.
14. Biedermann KA, Sun JR, Giaccia AJ, Tosto LM, Brown JM. seid mutation in mice confers hypersensitivity to ionizing radiation and a deficiency in DNA double-strand break repair. Proc Natl Acad Sci U S A 1991; 88:1394-7.
15. Collis SJ, Swartz MJ, Nelson WG, DeWeese TL. Enhanced radiation and chemotherapy-mediated cell killing of human cancer cells by small inhibitory RNA silencing of DNA repair factors. Cancer Res 2003; 63:1550-4.
16. Peng Y, Zhang Q, Nagasawa H, Okayasu R, Liber HL, Bedford JS. Silencing expression of the catalytic subunit of DNA-dependent protein kinase by small interfering RNA sensitizes human cells for radiation-induced chromosome damage, cell killing, and mutation. Cancer Res 2002;62:6400-4.
17. Geng L, Tan J, Himmelfarb E, et al. A specific antagonist of the p110δ catalytic component of phosphatidylinositol 3′-kinase, IC486068, enhances radiation-induced tumor vascular destruction. Cancer Res 2004;64:4893-9.
18. Schueneman AJ, Himmelfarb E, Geng L, et al. E. SU11248 maintenance therapy prevents tumor regrowth after fractionated irradiation of marine tumor models. Cancer Res 2003;63:4009-16.
19. Kashishian A, Douangpanya H, Clark D, et al. DNA-dependent protein kinase inhibitors as drug candidates for the treatment of cancer. Mol Cancer Ther 2003:2; 1257-64.
20. Iliakis G. The role of DNA double strand breaks in ionizing radiation-induced killing of eukaryotic cells. Bioessays 1991;13:641-8.
21. Lemay M, Wood KA. Detection of DNA damage and identification of UV-induced photoproducts using the Comet Assay kit. Biotechniques 1999;27: 846-51.
22. Baumann P, West SC. DNA end-joining catalyzed by human cell-free extracts. Proc Natl Acad Sci U S A 1998; 95:14066-70.
23. Edwards E, Geng L, Tan J, Onishko H, Donnelly E, Hallahan DE. Phosphatidylinositol 3-kinase/Akt signaling in the response of vascular endothelium to ionizing radiation. Cancer Res 2002;62:4671-7.